Vaccine safety

Publication

Expert opinion on rotavirus vaccination in infancy

expert opinion -

Peer-Reviewed Publication

Immunisation information systems - Useful tools for monitoring vaccination programmes in EU/EEA countries, 2016

2017

Peer-Reviewed Publication

Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?

2016

Peer-Reviewed Publication

Vaccine hesitancy among healthcare workers in Europe: A qualitative study

2016

Publication

Vaccine hesitancy among healthcare workers and their patients in Europe

technical report -

News

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2

ECDC comment -

Peer-Reviewed Publication

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines

2015

Peer-Reviewed Publication

Safety of human papillomavirus vaccines: A review

2015

News

Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands

ECDC comment -

Peer-Reviewed Publication

The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation

2014

Peer-Reviewed Publication

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: A multinational self-controlled case series in Europe

2014

News

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland

ECDC comment -

News

New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix

ECDC comment -

News

Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)

ECDC comment -

Peer-Reviewed Publication

Modelling the risk-benefit impact of H1N1 influenza vaccines

2013

Peer-Reviewed Publication

The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

2013

News

Narcolepsy and Pandemrix Vaccine – an association in adults as well as children

ECDC comment -

Publication

Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation

technical report -

Publication

Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination

technical report -

News

New ECDC technical report on “Narcolepsy in association with pandemic influenza vaccination – a multi-country European epidemiological investigation”

news -

News

Report on the association between the 2009 pandemic vaccine (Pandemrix®) and narcolepsy – Republic of Ireland

ECDC comment -

News

Association of childhood narcolepsy and cataplexy and receipt of a pandemic influenza vaccine in Finland in 2009-10 – First papers in a peer review journal

ECDC comment -

Event

Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCO

23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden

News

Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Pre-Term European Infants: A Randomized Phase IIIb Study

ECDC comment -

Peer-Reviewed Publication

Opportunities and challenges of Web 2.0 for vaccination decisions

2012

Peer-Reviewed Publication

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark

2012

News

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine in Children Previously Immunized With 7-valent Pneumococcal Conjugate Vaccine

ECDC comment -

News

Recommendation by the European Medicines Agency concerning Pandemrix vaccination and reports of narcolepsy in children and adolescents

ECDC comment -

News

EMA's Committee for Medicinal Products for Human Use (CHMP) issues opinion on narcolepsy and vaccination with Pandemrix®

news -

News

No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in Europe

ECDC comment -

News

Case inventory study from Sweden concerning association of Pandemrix vaccination and reports of narcolepsy with cataplexy in children and adolescents

ECDC comment -

News

The real issues in vaccine safety

ECDC comment -

News

European Medicines Agency (EMA) 2009 Influenza Pandemic Evaluation

ECDC comment -

News

Narcolepsy following pandemic influenza A H1N1 2009 vaccination - ECDC update: the European Medicines Agency interim measures for Pandemrix

ECDC comment -

News

Swedish MPA publishes interim results of a cohort study assessing the risk of narcolepsy after vaccination with Pandemic influenza vaccine Pandemrix®

ECDC comment -

News

Reports of cases of narcolepsy and cataplexy in children and adolescents in Finland, Iceland, and Sweden

ECDC comment -

News

ECDC – VAESCO investigation into narcolepsy

ECDC comment -

Peer-Reviewed Publication

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)

2011

Peer-Reviewed Publication

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe

2011

News

Safety experience of influenza vaccination in pregnant women in the US over a 20-year period

ECDC comment -

News

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

ECDC comment -

News

Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom

ECDC comment -

News

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers - Yeh SH et al. Pediatrics 2010; 126(3): e493-e505

ECDC comment -

News

Update of the EMA European Pharmacovigilance Report

ECDC comment -

News

Three 2009 Pandemic Vaccines now on the way to being licensed for use outside the Pandemic

ECDC comment -

News

Vaccine Safety - US Department of Health and Human Services publishes 2009 pandemic influenza A(H1N1) vaccine safety risk assessment

ECDC comment -

News

Vaccine Safety - Update of the EMA’s European Pharmacovigilance Report

ECDC comment -

News

Ninth Update of EMA Pharmacovigilance Report, 3 Feb 2010

ECDC comment -

Peer-Reviewed Publication

Experience and lessons from surveillance and studies of the 2009 pandemic in Europe

2010

Peer-Reviewed Publication

Moderate pandemic, not many dead - Learning the right lessons in Europe from the 2009 pandemic

2010

Peer-Reviewed Publication

Measles still spreads in Europe: Who is responsible for the failure to vaccinate?

2010

Peer-Reviewed Publication

Monitoring and assessing vaccine safety: A European perspective

2010

News

Background rates of disease useful for assessment of pandemic vaccine safety

ECDC comment -

Peer-Reviewed Publication

Pandemic influenza A(H1N1) 2009 vaccines in the European Union.

2009

Peer-Reviewed Publication

Assessing vaccines and vaccination programmes in the field

2009

Peer-Reviewed Publication

A Human Case Of Swine Influenza Virus Infection In Europe - Implications For Human Health And Research

2009

Peer-Reviewed Publication

Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings

2008

Peer-Reviewed Publication

European Immunization Week 2008 - time for reflection.

2008

Peer-Reviewed Publication

European Centre for Disease Prevention and Control issues guidance for the introduction of human papillomavirus (HPV) vaccines in European Union countries.

2008

Event

Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines

23 Oct 2015
Geneva, Switzerland